Search Within

Melanoma Disease Management Team

Formats
  1. Journal Article (1604)
  2. Meeting Abstract (791)
  3. Book Section (104)
  4. Review (72)
  5. Editorial (58)
  6. Research Letter (45)
  7. Guidelines (26)
  8. Conference Paper (22)
  9. Correspondence (21)
  10. Miscellaneous (16)
  11. Book Whole (11)
Groups
  1. Department of Medicine (1690)
  2. Survivorship Research (1193)
  3. Solid Tumor Oncology Division (1052)
  4. Department of Pathology and Laboratory Medicine (957)
  5. Surgery (947)
  6. Melanoma and Immunotherapeutics Service (793)

More Groups

People
  1. Klaus Busam (698)
  2. Daniel Coit (543)
  3. Allan Halpern (401)
  4. Michael Postow (369)
  5. Alexander Shoushtari (247)
  6. Jedd Wolchok (222)

More People

Years
  1. 2025 (89)
  2. 2024 (138)
  3. 2023 (160)
  4. 2022 (167)
  5. 2021 (149)
  6. 2020 (142)

More Years

Publications
  1. Journal of Clinical Oncology (269)
  2. Annals of Surgical Oncology (221)
  3. Journal of the American Academy of Dermatology (123)
  4. Journal of Investigative Dermatology (84)
  5. Modern Pathology (67)
  6. American Journal of Surgical Pathology (64)

More Publications

Publishers
  1. Springer (341)
  2. American Society of Clinical Oncology (284)
  3. Elsevier Inc. (231)
  4. Lippincott Williams & Wilkins (229)
  5. Wiley Blackwell (162)
  6. Elsevier Science, Inc. (160)

More Publishers

Results (2770)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Determinants of overall survival in patients with metastatic uveal melanoma
    Journal Article

    Demkowicz, P.; Pointdujour-Lim, R.; Miguez, S.; Lee, Y.; Jones, B. S. C. L.; Barker, C. A.; Bosenberg, M.; Abramson, D. H.; Shoushtari, A. N.; Kluger, H.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • Timing of adjuvant immunotherapy in stage III melanoma, does it matter?
    Journal Article

    Rhodin, K. E.; Jung, S. H.; Elleson, K.; DePalo, D.; Straker, R.; McKinley, S.; Beekman, K.; Parker, L.; Chen, S.; Iyer, M. K.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Lorlatinib tolerability and association with clinical outcomes in patients with advanced ALK- or ROS1-rearranged NSCLC: A brief report
    Journal Article

    Thummalapalli, R.; Choudhury, N. J.; Ehrich, F.; Beardslee, T.; Brazel, D.; Zhang, S. S.; Merchant, S.; Chen, M. F.; Heller, G.; Ramalingam, S. S.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • A topic modeling approach reveals the dynamic T cell composition of peripheral blood during cancer immunotherapy
    Journal Article

    Peng, X.; Lee, J.; Adamow, M.; Maher, C.; Postow, M. A.; Callahan, M. K.; Panageas, K. S.; Shen, R.
    Cell Reports Methods (2023)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Timing of adjuvant immunotherapy in stage III melanoma, does it matter?
    Miscellaneous

    Rhodin, K. E.; Jung, S. H.; Elleson, K.; DePalo, D.; Straker, R.; McKinley, S.; Beekman, K.; Parker, L.; Chen, S.; Iyer, M. K.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Cutaneous neuroendocrine mucinous carcinomas are low-grade but may be associated with other cancers
    Journal Article

    Adkins, K. E.; Busam, K.; Pulitzer, M.
    American Journal of Surgical Pathology (2023)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Betof Warner, A.; Postow, M. A.; Panageas, K.; Smithy, J. W.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 2/3 trial in progress on tebentafusp as monotherapy and in combination with pembrolizumab in HLA-A*02:01+ patients with previously treated advanced non-uveal melanoma (TEBE-AM)
    Meeting Abstract

    Davar, D.; Ikeguchi, A.; Buchbinder, E. I.; Shoushtari, A. N.; Seedor, R. S.; Bernicker, E.; Weiss, S. A.; Daniels, G. A.; Panella, T. J.; Ryan, H. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Predictors of benefit to radiation for oligoprogressive disease in EGFR -mutant metastatic non-small cell lung cancer patients treated with osimertinib
    Meeting Abstract

    Chen, M. F.; Ma, J.; Kris, M. G.; Gomez, D. R.; Yu, H. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Serum cytokines and autoantibodies to GM-CSF and immune-related colitis in ipilimumab-treated patients with cancer
    Meeting Abstract

    Gonzalez-Kozlova, E.; Del Valle, D.; Tuballes, K.; Barcessat, V.; King, S.; Huang, H. H.; Patel, M.; Cabal, R.; Ioannou, G.; Merand, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save